"Ruimei" triple blood cell separator - Taiwan Registration 3e96eac96014db9a71b86084f1b9bae9
Access comprehensive regulatory information for "Ruimei" triple blood cell separator in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 3e96eac96014db9a71b86084f1b9bae9 and manufactured by REV-MED, Inc.. The authorized representative in Taiwan is BUTICON INTERNATIONAL CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
3e96eac96014db9a71b86084f1b9bae9
DHA05603439909
Product Details
The TriCell PRP Kit is designed to remove blood from patients and centrifuge to prepare Platelet-rich plasma (PRP) for patient use.
B Hematology, pathology, and genetics
B.9245 Automated hemocytoseparator
Input;; QMS/QSD
Dates and Status
Apr 20, 2021
Apr 20, 2026